Hoerter Steven L. 4
4 · MBX Biosciences, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
Hoerter Steven L.
Director
Transactions
- Award
Stock option (right to buy)
2025-04-07+32,000→ 32,000 totalExercise: $6.00Exp: 2035-04-07→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]One-third of the shares underlying this option will vest and become exercisable on April 7, 2026, the anniversary of the date of grant, with the remainder vesting monthly over the subsequent two year period, subject to the Reporting Person's continued service on each such vesting date.